Frontiers in Oncology | Thoracic Oncology

Systematic Review

Published on 20 Dec 2024

Nanoparticle trends and hotspots in lung cancer diagnosis from 2006-2023: a bibliometric analysis

in Thoracic Oncology

Wang Yilun
Zhang Yaojing
Shi Hongcan

Frontiers in Oncology

doi 10.3389/fonc.2024.1453021

2,353 views
1 citation

Review

Published on 19 Dec 2024

Biomarkers for immunotherapy resistance in non-small cell lung cancer

in Thoracic Oncology

Catriona Rother
Tom John
Annie Wong

Frontiers in Oncology

doi 10.3389/fonc.2024.1489977

6,852 views
12 citations

Original Research

Published on 17 Dec 2024

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

in Thoracic Oncology

Aida Piedra
Sergio Martínez-Recio
Ainhoa Hernández
Teresa Morán
Edurne Arriola
Jordi Recuero-Borau
Manuel Cobo
Patricia Cordeiro
Joaquín Mosquera
Manuel Fernández

Frontiers in Oncology

doi 10.3389/fonc.2024.1510278

3,287 views
2 citations

Case Report

Published on 13 Dec 2024

Huge extramedullary hematopoiesis mass in the posterior mediastinum: a case report

in Thoracic Oncology

Zhao Junjun
Dong Lingjun
Ma Zhifeng
Zhang Chu
Wang Haiyong

Frontiers in Oncology

doi 10.3389/fonc.2024.1489785

1,570 views

Original Research

Published on 13 Dec 2024

Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

in Thoracic Oncology

Lele Huang
Weifang Kong
Yongjun Luo
Hongjun Xie
Jiangyan Liu
Xin Zhang
Guojin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1458374

1,795 views
2 citations

Original Research

Published on 12 Dec 2024

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals

in Thoracic Oncology

Valérie Labrie
Judith Lefebvre
Catherine Labbé
Kevin Jao
Mandy Malick
Serge Simard
Nicole Bouchard

Frontiers in Oncology

doi 10.3389/fonc.2024.1506172

1,934 views
1 citation

Original Research

Published on 12 Dec 2024

Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression

in Thoracic Oncology

Meiling Lan
Tianyun Wang
Diexiao Luo
Yan Chen
Wei Liang
Rui Kong
Qichao Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1472545

1,545 views

Case Report

Published on 11 Dec 2024

Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to immune checkpoint inhibitors: a case report

in Thoracic Oncology

Jian Wang
Bingyue Liu
Qinhong Zheng
Ruoshui Xiao
Jianxin Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1507658

1,924 views
5 citations

Case Report

Published on 11 Dec 2024

Primary pulmonary hyalinizing clear cell carcinoma with EWSR1 gene translocation: a case report

in Thoracic Oncology

Can-hui Jian
Shuai Luo
Jin-jing Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1509132

1,771 views
1 citation

Case Report

Published on 11 Dec 2024

Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features

in Thoracic Oncology

Ting Duan
Mingxin Xu
Haibo Zhang
Shengchang Wu
Haochu Wang
Zhenying Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1453895

2,638 views
5 citations

Review

Published on 09 Dec 2024

Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies

in Thoracic Oncology

Li Zhang
Feiyue Zhang
Gaofeng Li
Xudong Xiang
Haifeng Liang
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1422623

2,182 views

Original Research

Published on 06 Dec 2024

Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis

in Thoracic Oncology

Jiaying Deng
Lei Zhang
Zezhou Wang
Bin Li
Jiaqing Xiang
Longfei Ma
Hongcheng Zhu
Yuan Li
Kuaile Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1442212

2,191 views
4 citations

Perspective

Published on 05 Dec 2024

Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC

in Thoracic Oncology

Michelle Shiller
Melissa Johnson
Robert Auber
Sandip Pravin Patel

Frontiers in Oncology

doi 10.3389/fonc.2024.1459737

4,681 views
3 citations

Original Research

Published on 04 Dec 2024

Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy

in Thoracic Oncology

Yi Ge
Xiaoyu Liu
Yishi Xu
Yanwei Su
Yixin Li
Liping Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1485849

2,291 views
2 citations

Original Research

Published on 04 Dec 2024

A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients

in Thoracic Oncology

Lifang Zhang
Ying Liu
Di Han
Yan Wang
Fanqi Geng
Wei Ding
Xuejuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1463805

1,793 views

Case Report

Published on 29 Nov 2024

Anesthetic management of acute right heart failure in patients with pulmonary embolism undergoing AngioJet pulmonary embolectomy: a case report

in Thoracic Oncology

Shasha Zhang
Fangeng Meng
Chao Zhou
Yiwen Zhang
Huaqin Liu
Yuanyuan Rong

Frontiers in Oncology

doi 10.3389/fonc.2024.1477922

2,612 views

Case Report

Published on 29 Nov 2024

Case report: A case of giant malignant solitary fibrous tumor of the pleura with Doege-Potter’s syndrome and review of the literature

in Thoracic Oncology

Jie Li
Hong-Tao Tang
Qing Liu
Cai-Han Li
Wei-Yang Chen
Zeng-Wei Yu
Lei Wang
Lin Lin
Jin-Lan Zhao
Chun-Yan Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1437535

1,778 views
1 citation

Original Research

Published on 27 Nov 2024

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

in Thoracic Oncology

Zachary D. Wallen
Mary K. Nesline
Marni Tierno
Alison Roos
Erica Schnettler
Hatim Husain
Pratheesh Sathyan
Brian Caveney
Marcia Eisenberg
Eric A. Severson

Frontiers in Oncology

doi 10.3389/fonc.2024.1473327

4,013 views

Original Research

Published on 26 Nov 2024

The diagnostic efficacy of seven autoantibodies in early detection of ground-glass nodular lung adenocarcinoma

in Thoracic Oncology

Hua Guo
Wei Zhao
Chunsun Li
Zhen Wu
Ling Yu
Miaoyu Wang
Yuanhui Wei
Zirui Wang
Shangshu Liu
Yue Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1499140

1,593 views
1 citation

Case Report

Published on 26 Nov 2024

Exploring the multifaceted challenges of gastrointestinal metastases in lung adenocarcinoma: a case report highlighting diagnostic dilemmas and therapeutic innovations

in Thoracic Oncology

Xinxin Xu
Qian Zhou
Peng Chen
Chengzhou Du
Yonghua Huang
Xiaoxin Gao
Shumei Xu
Jinling Wu
Tianxiao He
Hongtao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1486371

1,622 views
1 citation

Case Report

Published on 19 Nov 2024

Treatment of recurrent tracheal adenoid cystic carcinoma with a covered airway stent loaded with Iodine-125 seeds: a 5-year follow-up case report

in Thoracic Oncology

Zhen Yang
Yafei Wang
Zhenhua Li
Shuang Geng
Yi Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1450508

1,553 views
1 citation

Original Research

Published on 15 Nov 2024

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features

in Thoracic Oncology

Peng Hao
Yinghong Yu
Chan-Tao Huang
Fang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1464555

2,213 views

Case Report

Published on 13 Nov 2024

Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors

in Thoracic Oncology

Roberto Rosenfeld
Silvia Riondino
Giusy Parisi
Giovanni Maria Iannantuono
Rexhina Ajdhoni
Francesco Torino
Sabrina Mariotti
Mario Roselli

Frontiers in Oncology

doi 10.3389/fonc.2024.1417776

1,598 views
3 citations

Case Report

Published on 13 Nov 2024

Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer

in Thoracic Oncology

Waleed Kian
Belal Krayim
Betsy Giles
Nasim A. Elkiaan
Amjad Idris
Daniel Fink
Nir Peled
Laila C. Roisman

Frontiers in Oncology

doi 10.3389/fonc.2024.1286116

2,567 views
2 citations

1,913 articles

articles

Nanoparticle trends and hotspots in lung cancer diagnosis from 2006-2023: a bibliometric analysis

Biomarkers for immunotherapy resistance in non-small cell lung cancer

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Huge extramedullary hematopoiesis mass in the posterior mediastinum: a case report

Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals

Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression

Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to immune checkpoint inhibitors: a case report

Primary pulmonary hyalinizing clear cell carcinoma with EWSR1 gene translocation: a case report

Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features

Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies

Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis

Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC

Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy

A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients

Anesthetic management of acute right heart failure in patients with pulmonary embolism undergoing AngioJet pulmonary embolectomy: a case report

Case report: A case of giant malignant solitary fibrous tumor of the pleura with Doege-Potter’s syndrome and review of the literature

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

The diagnostic efficacy of seven autoantibodies in early detection of ground-glass nodular lung adenocarcinoma

Exploring the multifaceted challenges of gastrointestinal metastases in lung adenocarcinoma: a case report highlighting diagnostic dilemmas and therapeutic innovations

Treatment of recurrent tracheal adenoid cystic carcinoma with a covered airway stent loaded with Iodine-125 seeds: a 5-year follow-up case report

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features

Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors

Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer